In the term group, newborns with cord albumin 2.8 g/dL developed neonatal hyperbilirubinemia in 61.2% of cases, according to Reshad et al. 6.5% of infants with cord serum albumin levels greater than 3.4 g/dL experienced substantial neonatal hyperbilirubinemia. The gene discussed is ALB; the disease is Hyperbilirubinemia.